Halaman 3 - Tumor neuroendokrin pankreas Dokter Terbaik - TOP-85 dokter

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Memiliki pengalaman lebih dari 10 tahun di bidang onkologi
• Pernah bekerja di Klinik Onkologi Ankara dan Rumah Sakit Pelatihan dan Penelitian Regional Erzurum
• Dipromosikan menjadi Associate Professor pada tahun 2016
• Menempuh pendidikan kedokteran di Universitas Selcuk

Profesor Keil berspesialisasi dalam teknik pencitraan tingkat lanjut untuk tumor neuroendokrin pankreas di Rumah Sakit Akademik Solingen.

• Lulus dengan pujian dari Universitas Julius-Maximilian Würzburg
• Ahli MRI, CT, dan ultrasound untuk intervensi kompleks
• Kepala Dokter Radiologi Diagnostik dan Intervensional sejak 2022
• Menjalani pelatihan di bawah Profesor Rolf W. Günther yang ternama di Aachen

Kepala Dokter di pusat kanker interdisipliner bersertifikat – Dr. Fox berspesialisasi dalam tumor neuroendokrin pankreas dengan fokus pada diagnostik molekuler dan terapi target.

• Lebih dari 15 tahun pengalaman di bidang onkologi dan hematologi
• Spesialisasi dalam genetika – mengoptimalkan rencana perawatan pribadi
• Peneliti aktif dalam biologi molekuler untuk terapi kanker
• Anggota asosiasi onkologi Jerman dan Amerika

Spesialisasi dalam viroterapi – bidang imunologi mutakhir – Dr. Jaunalksne membawa lebih dari 30 tahun pengalaman dalam pengobatan tumor neuroendokrin pankreas.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada pengintegrasian pendekatan imunoterapi untuk hasil yang lebih baik

Dr. Ayala Hubert adalah Kepala Pusat Kanker Gastrointestinal di Hadassah Medical Center – spesialis dalam kanker sistem pencernaan.

• 33 tahun pengalaman sebagai ahli onkologi medis dan radioterapis
• Terlatih dalam psikologi di Hebrew University – memberikan pendekatan manusiawi pada perawatan kanker
• Memiliki sertifikasi dewan baik dalam Onkologi maupun Radioterapi
• Anggota aktif Komite Israel untuk Kanker Gastrointestinal

Profesor Gul Alco berspesialisasi dalam onkologi radiasi dengan pengalaman lebih dari dua dekade, saat ini bertugas di Universitas Medipol Istanbul.

• Profesor di bidang Onkologi Radiasi sejak 2021
• Menyelesaikan residensi di Universitas Kadir Has
• Pengalaman luas dalam mengobati tumor neuroendokrin pankreas
• Keahlian dalam teknik terapi radiasi tingkat lanjut

Assoc. Prof. Nail Paksoy berspesialisasi dalam tumor neuroendokrin pankreas, didukung oleh sertifikasi dewan ESMO dan penelitian ekstensif di bidang onkologi.

• Fellowship Onkologi Medis di Institut Onkologi Universitas Istanbul
• Penelitian yang diterbitkan mengenai strategi pengobatan untuk tumor neuroendokrin
• Berpartisipasi dalam uji klinis yang berfokus pada terapi kanker stadium lanjut
• Peran akademik di Universitas Medipol Istanbul

Dr. Muzaffer Al berspesialisasi dalam bedah laparoskopi untuk tumor neuroendokrin pankreas di Rumah Sakit Büyük Anadolu.

• Terlatih dalam bedah laparoskopi tingkat lanjut dan onkologi di Universitas Istanbul
• Berspesialisasi dalam bedah antirefluks laparoskopi
• Berpengalaman dalam bedah bariatrik laparoskopi

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Alemdar berspesialisasi dalam tumor neuroendokrin pankreas di Kompleks Rumah Sakit Medical Park Antalya, dengan pelatihan ekstensif di bidang onkologi medis.

• Tersertifikasi dalam onkologi medis sejak 2018
• Memiliki lebih dari 15 tahun pengalaman dalam penyakit dalam dan onkologi
• Menjalani pelatihan di Universitas Akdeniz, sebuah institusi medis terkemuka
• Bekerja di rumah sakit terakreditasi JCI dengan unit onkologi tingkat lanjut

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

dr. Volkan Kinas berspesialisasi dalam bedah pankreas, dengan fokus pada tumor neuroendokrin di Rumah Sakit Büyük Anadolu.

• Berspesialisasi dalam bedah pankreas dan onkologi
• Menangani kasus kompleks yang melibatkan saluran empedu dan kanker lambung
• Berpengalaman dalam bedah metabolik bariatrik
• Bekerja dalam tim multidisiplin untuk perawatan komprehensif

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.